When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
CHMA - FDA OKs Chiasma's Mycapssa for growth hormone disorder
Chiasma Inc.
The FDA approves Chiasma's (CHMA-1.5%) Mycapssa (octreotide) for the long-term maintenance treatment of adult patients with acromegaly, a disorder in which the pituitary gland produces excessive amounts of growth hormone which causes bones in the hands, feet and face to increase in size.
More news on: Chiasma, Inc., Healthcare stocks news, Stocks on the move,